A new research study has shown that pancreatic cancer cells can be coaxed to revert back toward normal cells by introducing a protein called E47.
E47 binds to specific DNA sequences and controls genes involved in growth and differentiation. The research provides hope for a new treatment approach for the more than 40,000 people who die from the disease each year in the United States.
“For the first time, we have shown that overexpression of a single gene can reduce the tumor-promoting potential of pancreatic adenocarcinoma cells and reprogram them toward their original cell type. Thus, pancreatic cancer cells retain a genetic memory which we hope to exploit,” said Pamela Itkin-Ansari, Ph.D., adjunct professor in the Development, Aging, and Regeneration Program at Sanford-Burnham and lead author of the study published today in the journal Pancreas.
E47 turns the clock back
The study, a collaborative effort between Sanford-Burnham, UC San Diego, where Itkin-Ansari holds a joint appointment, and Purdue University, generated human pancreatic ductal adenocarcinoma cell lines to make higher-than-normal levels of E47. The increased amount of E47 caused cells to stall in the G0/G1 growth phase, and differentiate back toward an acinar cell phenotype.
In-vivo studies showed that when the reprogrammed cancer cells were introduced into mice, their ability to form tumors was greatly diminished compared to untreated adenocarcinoma cells.
“Presently, pancreatic adenocarcinoma is treated with cytotoxic agents, yet the average survival for patients post-diagnosis is merely six months, and the improvements in therapies are measured in days,” said Andrew M. Lowy, M.D., professor of surgery at the UC San Diego Moores Cancer Center and co-chair of the National Cancer Institute’s Pancreatic Cancer Task Force. “The finding that we can differentiate these cancer cells back to a non-threatening phenotype is encouraging. Indeed, there is a precedent for cell differentiation therapy in that the approach has been used to treat acute promyelocytic leukemia (APL) and some neuroblastomas successfully.”
“Our next step is to test primary patient-derived tumor tissue to determine whether E47 can produce similar results, potentially providing a novel therapeutic approach to combating this highly lethal disease,” said Itkin-Ansari. “Additionally, we are screening for molecules—potential drugs—that can induce overexpression of E47.”
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Curiosity and Creativity Fuel Advancements in Pancreatic Cancer Researchon November 30, 2020 at 10:47 am
From cancer to COVID to computer technology, innovation often begins as a spark of creativity lit by a researcher's curiosity. Whether viewing existing research through a different lens or bringing a ...
- Two thousand pancreatic cancer patients die in lockdownon November 29, 2020 at 2:09 am
Sign up for FREE now and never miss the top Royal stories again. Figures collated by Pancreatic Cancer Action, show a 17 percent drop in pancreatic cancer patient survival linked to suspended ...
- Pancreatic Cancer Therapeutics Diagnostics Market Growth Rate and Development Analysis to 2022on November 26, 2020 at 8:09 am
The uncontrolled growth of cells in the pancreas causes pancreatic cancer. It is an abnormal, unrestrained growth of ...
- Pancreatic cancer month - join the fight | Houghtaling and Downeyon November 24, 2020 at 3:46 am
By supporting research, staying vigilant about our own health and risk factors, and making our families and friends aware of this deadly disease, we will help drive the search for hope and a cure." ...
- U.S. pancreatic cancer deaths are expected to total 47,500 in 2020on November 23, 2020 at 6:08 pm
In 2020, deaths from pancreatic cancer in the United States are expected to total 47,500, according to the National Cancer Institute.
- Dover woman honors dad with fight against pancreatic canceron November 21, 2020 at 6:05 am
Kelly Glennon’s father was diagnosed with Stage 4 pancreatic cancer in March 2010. Two months later, he was gone.
- Alex Trebek raises awareness of ‘terrible’ pancreatic cancer in pre-recorded ‘Jeopardy!’ videoon November 20, 2020 at 3:39 pm
During the beginning of Thursday’s episode of “Jeopardy!”, the late veteran TV personality shared a pre-taped message on the day dedicated to raising awareness and funds for pancreatic cancer.
- Alex Trebek spreads awareness about 'terrible' pancreatic cancer on pre-recorded 'Jeopardy!'on November 20, 2020 at 8:33 am
In honor of World Pancreatic Cancer Day, "Jeopardy!" aired a pre-recorded show featuring Alex Trebek's touching message about pancreatic cancer.
- The University of Verona and IntraOp® Announce PancFORT Trial for Pancreatic Canceron November 20, 2020 at 3:41 am
IntraOp Medical Corporation and the University of Verona in Italy announced today the enrollment of the first patient in the PancFORT Trial: A phase II study of primary chemotherapy, stereotactic body ...
- Pancreatic Cancer Collective Announces New PSA Campaign With Keesha Sharp To Raise Awareness About Pancreatic Cancer Clinical Trialson November 20, 2020 at 1:23 am
The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer (SU2C), announced today the launch of a new public service announcement (PSA) campaign, in ...
via Bing News